UNIGE document Scientific Article
previous document  unige:25468  next document
add to browser collection
Title

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Authors
Chatzidionysiou, Katerina
Lie, Elisabeth
Nasonov, Evgeny
Lukina, Galina
Hetland, Merete Lund
Tarp, Ulrik
van Riel, Piet L C M
show hidden authors show all authors [1 - 14]
Published in Annals of the Rheumatic Diseases. 2011, vol. 70, no. 9, p. 1575-80
Abstract To assess the 6-month effectiveness of the first rituximab (RTX) course in rheumatoid arthritis (RA) and to identify possible predictors of response.
Keywords AdultAgedAntibodies, Monoclonal, Murine-Derived/therapeutic useAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapy/immunologyAutoantibodies/bloodBiological Markers/bloodDrug Evaluation/methodsEpidemiologic MethodsFemaleHumansMaleMiddle AgedPeptides, Cyclic/immunologyPrognosisRheumatoid Factor/bloodTreatment FailureTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Identifiers
PMID: 21571731
Full text
Article (Published version) (231 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
CHATZIDIONYSIOU, Katerina et al. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. In: Annals of the Rheumatic Diseases, 2011, vol. 70, n° 9, p. 1575-80. https://archive-ouverte.unige.ch/unige:25468

111 hits

0 download

Update

Deposited on : 2013-01-14

Export document
Format :
Citation style :